Medicine information
Uses & overview
ST GLIPTIN GM 50+1000+2, from Steris Healthcare, is a triple-combination oral antidiabetic formulation containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg. These three active ingredients work through different mechanisms to help manage blood glucose levels in adults with type 2 diabetes mellitus when the combination is considered appropriate by their treating physician. Composition Each tablet contains: Sitagliptin: 50 mg Metformin Hydrochloride: 1000 mg Glimepiride: 2 mg Manufacturer / Brand Owner: Steris Healthcare Key Product Features Triple-combination oral antidiabetic formulation. Contains Sitagliptin, Metformin Hydrochloride, and Glimepiride. Combines complementary mechanisms of action for blood glucose management. Intended for physician-supervised type 2 diabetes management. Uses of ST GLIPTIN GM 50+1000+2 ST GLIPTIN GM 50+1000+2 may be prescribed for adults with type 2 diabetes mellitus when the treating physician determines that this combination is suitable for their individual treatment requirements. How ST GLIPTIN GM 50+1000+2 Works Sitagliptin 50 mg: Inhibits the DPP-4 enzyme, helping support incretin activity and glucose-dependent insulin secretion. Metformin Hydrochloride 1000 mg: Helps reduce glucose production in the liver and improves the body's response to insulin. Glimepiride 2 mg: Belongs to the sulfonylurea class of antidiabetic medicines and stimulates insulin release from the pancreas. Together, these ingredients support blood glucose control through complementary mechanisms when taken as prescribed. Important Safety Information ST GLIPTIN GM 50+1000+2 is a prescription medicine and should be used only under medical supervision. Glimepiride may cause hypoglycaemia (low blood sugar), particularly when meals are skipped or delayed. Metformin may cause gastrointestinal side effects and, rarely, lactic acidosis. Sitagliptin has been associated with pancreatitis and other uncommon but potentially serious adverse effects. Inform your doctor if you have kidney or liver problems, a history of pancreatitis, or are taking other medicines that may affect blood glucose. Appropriate kidney function assessment and regular blood glucose monitoring are important during treatment. Disclaimer: This information is for educational purposes only and does not replace professional medical advice or the approved prescribing information. About Steris Healthcare Steris Healthcare is the company associated with the ST GLIPTIN GM 50+1000+2 brand. For company-specific information, product availability, manufacturing details, and distribution enquiries, refer to the official company information supplied by Steris Healthcare.
How to use
Take ST GLIPTIN GM 50+1000+2 exactly as prescribed by your doctor. Follow the recommended dosage and timing provided by your healthcare professional and the approved product instructions. Take the medicine with food if directed by your doctor or the product labelling. Maintain regular meal timings to help reduce the risk of low blood sugar associated with Glimepiride. Monitor your blood glucose as advised, and do not change the dose or discontinue treatment without consulting your doctor.
Storage
Store ST GLIPTIN GM 50+1000+2 in its original packaging in a cool, dry place, away from direct sunlight and moisture. Follow the storage conditions printed on the product packaging. Keep out of reach of children and do not use the medicine after its expiry date.
